Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

[1]  R. Bates,et al.  Effect of 17‐β‐estradiol and testosterone on aryl hydrocarbon hydroxylase activity in mouse tissues in vivo and in cell culture , 1970, International journal of cancer.

[2]  E. Jensen,et al.  Mechanism of action of the female sex hormones. , 1972, Annual review of biochemistry.

[3]  V. K. Rowe,et al.  Toxicology of chlorinated dibenzo-p-dioxins. , 1973, Environmental health perspectives.

[4]  D. Nebert,et al.  Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. , 1974, The Journal of biological chemistry.

[5]  D. Nebert,et al.  Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse , 1975, Journal of cellular physiology.

[6]  P. E. Phillips,et al.  Tetrachlorodibenzodioxin: an accidental poisoning episode in horse arenas. , 1975, Science.

[7]  R. A. Neal,et al.  Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in larval and adult forms ofRana catesbeiana , 1976, Bulletin of environmental contamination and toxicology.

[8]  C. Bastomsky.  Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1977, Endocrinology.

[9]  B. O’Malley,et al.  MECHANISMS OF STEROID HORMONE ACTION , 1977 .

[10]  G. Stancel,et al.  Regulation of the uterine response to estrogen by thyroid hormone. , 1978, Endocrinology.

[11]  R. Rumbaugh,et al.  Requirement of the pituitary gland for gonadal hormone effects on hepatic drug metabolism in rats. , 1979, The Journal of pharmacology and experimental therapeutics.

[12]  F A Smith,et al.  Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the diet. , 1979, Toxicology and applied pharmacology.

[13]  P. O'Brien,et al.  Differential effects of antioxidants, steroids and other compounds on benzo(a)pyrene 3-hydroxylase activity in various tissues of rat. , 1979, British Journal of Cancer.

[14]  J. Marniemi,et al.  Different effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucuronide conjugation of various aglycones. Studies in Wistar and Gunn rats. , 1979, Toxicology and applied pharmacology.

[15]  R. A. Neal,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigs. , 1979, Toxicology and applied pharmacology.

[16]  E. Glover,et al.  2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus. , 1980, Molecular pharmacology.

[17]  R. A. Neal,et al.  Tissue distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the Golden Syrian hamster. , 1980, Toxicology and applied pharmacology.

[18]  S. Stohs,et al.  Effect of acute and chronic estrone, estradiol, and estriol treatment on hepatic, pulmonary, and intestinal mixed-function mon-oxygenase activities in female rats. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[19]  A. Hsueh,et al.  Inhibition of ovarian and testicular steroidogenesis by epidermal growth factor. , 1981, Endocrinology.

[20]  R. Kociba,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin: acute oral toxicity in hamsters. , 1981, Toxicology and applied pharmacology.

[21]  I. White.  Destruction of liver haem by norethindrone. Conversion into green pigments. , 1981, The Biochemical journal.

[22]  V. Mukku,et al.  Hormonal control of uterine growth: the effect of hypothyroidism on estrogen-stimulated cell division. , 1981, Endocrinology.

[23]  J. Gustafsson,et al.  Differential effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on nuclear RNA polymerase activity in the rat liver and thymus. , 1982, Biochemical pharmacology.

[24]  J. Li,et al.  Effect of steroid hormone treatment on aryl hydrocarbon hydroxylase activity in the Syrian hamster kidney. , 1983, Biochemical pharmacology.

[25]  I. Sipes,et al.  Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. , 1983, Toxicology and applied pharmacology.

[26]  A. N. Tucker,et al.  Estrogen immunosuppression is regulated through estrogenic responses in the thymus. , 1984, Journal of immunology.

[27]  J. Gorski,et al.  Remodeling the estrogen receptor model , 1984, Molecular and Cellular Endocrinology.

[28]  C. Grossman.  Regulation of the immune system by sex steroids. , 1984, Endocrine reviews.

[29]  B. O’Malley.  Steroid hormone action in eucaryotic cells. , 1984, The Journal of clinical investigation.

[30]  G. Greene,et al.  Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells , 1984, Nature.

[31]  F. Matsumura,et al.  Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Lakshmanan,et al.  Effect of oestradiol-17 beta on uterine epidermal growth factor concentration in immature mice. , 1984, Acta endocrinologica.

[33]  V. Mukku.  Regulation of epidermal growth factor receptor levels by thyroid hormone. , 1984, The Journal of biological chemistry.

[34]  J. Gustafsson,et al.  The rat liver receptor protein for 2,3,7,8-Tetrachlorodibenzo-p-dioxin: A comparison with steroid hormone receptors , 1985 .

[35]  M. P. Arlotto,et al.  Effect of thyroid hormones on liver microsomal enzyme induction in rats exposed to 2,3,7,8,-tetra-chlorodibenzo-p-dioxin , 1985 .

[36]  K. Chae,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity. , 1985, Environmental health perspectives.

[37]  V. Mukku,et al.  Regulation of epidermal growth factor receptor by estrogen. , 1985, The Journal of biological chemistry.

[38]  Robert W. Moore,et al.  Thyroid status and thermogenesis in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1986, Toxicology and applied pharmacology.

[39]  R. Dickson,et al.  Role of estrogens in the malignant progression of breast cancer: new perspectives , 1986 .

[40]  R. Cooper,et al.  Pituitary function following treatment with reproductive toxins. , 1986, Environmental health perspectives.

[41]  C. Jefcoate,et al.  Inhibition of ACTH action on cultured bovine adrenal cortical cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin through a redistribution of cholesterol. , 1986, The Journal of biological chemistry.

[42]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[43]  L. Hudson,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. , 1986, Toxicology and applied pharmacology.

[44]  R. Peterson,et al.  Hypercholesterolemia and the regulation of adrenal steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. , 1986, Toxicology and applied pharmacology.

[45]  L. Birnbaum,et al.  Effects of thyroid hormones on the induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL6N mice , 1986 .

[46]  T. Umbreit,et al.  Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic cytochrome P-450 and mouse uterus. , 1986, Toxicology letters.

[47]  K. Fuxe,et al.  Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. , 1987, Endocrine reviews.

[48]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[49]  P. Sawchenko,et al.  Localization, secretion, and action of inhibin in human placenta. , 1987, Science.

[50]  I. Sipes,et al.  Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down-regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1987, Toxicology and applied pharmacology.

[51]  M. Romkes,et al.  Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. , 1987, Toxicology and applied pharmacology.

[52]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.